Tilray raises CA$60M to sharply boost global cannabis production
Tilray said it raised 60 million Canadian dollars ($47 million) in financing that will allow the licensed producer…
News February 8
Latest In: Aphria
Labeling error spurs Canada’s Aphria to recall medical cannabis
A licensed producer of medical marijuana in Ontario has recalled a small amount of dried marijuana due to…
News January 31
Aphria to buy Nuuvera for CA$826 million, plans to ‘dominate’ international marijuana market
Mergers and acquisitions in Canada’s marijuana sector are showing no signs of letting up. The latest deal brings…
News January 29
Italy addresses ‘systematic’ medical marijuana shortage with help from Canadian companies
Two Canadian-based companies are turning to acquisitions and supply agreements to address a “systematic” shortfall of medical marijuana…
News January 22
Tilray signs medical cannabis supply deal with Canada’s Shoppers Drug Mart
The largest pharmacy chain in Canada locked up another major supplier of medical marijuana, as drugstore chains across…
News January 19
Canadian-listed marijuana company buys Florida MMJ license holder for $48M
A New York-based marijuana investment company used cash and its Canadian-listed shares to fund a $48 million acquisition of…
News January 17
Canadian regulatory group reviews US risk disclosure for cannabis stocks
An umbrella group for Canada’s securities regulators is reviewing whether its disclosure-based guidelines for companies with U.S. marijuana-related…
News January 16
Canadian marijuana grower spends CA$233M on British Columbia, Australia deals
One of Canada’s largest licensed medical marijuana producers got even bigger, buying rival British Columbia cultivator Broken Coast…
News January 15
Canadian cannabis companies ink deals for nearly CA$1B in funding in 10 days
Capital is pouring into the Canadian marijuana sector faster than ever, as companies prepare for the country’s anticipated…
News January 12Featured
1
Latest Sponsored
